Insilico Medicine Announces an AI-driven PROTAC R&D Collaboration with Arvinas
- Monday, August 9, 2021, 8:22
- Finance
- Add a comment
HONG KONG, Aug. 9, 2021 /PRNewswire/ — Insilico Medicine is proud to announce an R&D collaboration with Arvinas (NASDAQ: ARVN). This strategic partnership will involve Insilico Medicine’s AI-augmented platforms and close cooperation between Arvinas’ and Insilico Medicine’s scientists on…
About the Author
adminasapcorp has written 41552 stories on this site.